Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Tempo launches "Receiving Policy" feature, allowing accounts to restrict accepted token types and sender addresses

Tempo launches "Receiving Policy" feature, allowing accounts to restrict accepted token types and sender addresses

ForesightNewsForesightNews2026/07/14 02:51
Show original

Foresight News reports that the payment public chain Tempo has launched the Receive Policies feature, allowing accounts to restrict receivable tokens and sender addresses at the protocol level. This optional feature lets accounts configure accepted asset types, permitted sender addresses, and recovery permissions for rejected transfers. If a transfer does not comply with the receive policy, the transaction can still be successfully executed at the protocol level, but the funds will be routed to a guardian mechanism and a receipt will be generated for handling by the designated recovery party. This feature is applicable to scenarios such as exchanges, custodial institutions, payment channels, and deposit channels, effectively preventing unrelated assets from entering accounts, and transforming rejected transfers into manageable recovery processes instead of asset loss.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas